Medtronic news from FiercePharma
NewsSPOTLIGHT: Medtronic to shed 1,100 jobs
Stalling sales of implantable defibrillators have prompted device maker Medtronic to cut 1,100 jobs; that's on top of 900 positions cut last year. The company employs nearly 40,000 total. Read more...
AAMC: Ban pharma gifts at med schools
Will all medical schools bar the door to pharma giveaways? The Association of American Medical Colleges hopes so. After two years of study, the influential group drafted a policy that would ban drug Read more...
Arms twisted, pharma promises disclosure
Pharma knows that self-regulation is the best kind. That's why 12 drug and device makers have promised Sen. Chuck Grassley that they are working on plans to disclose CME grants. You know, the money Read more...
FDA wants to lengthen stent testing
Looking for hard evidence that the FDA is tightening approval standards? Here it is. The agency today proposed tougher clinical trial guidelines for drug-coated stents. Rather than letting new Read more...
SPOTLIGHT: FDA deems Medtronic warning a 'recall'
Oh, by the way, that was a recall. The FDA tells Medtronic that its January warning to doctors--of the increased inflammation risk when its drug infusion systems SynchroMed and IsoMed were used with Read more...
Grassley takes aim at Prodisc
Yet another medical device maker has been called on the Congressional carpet. Sen. Charles Grassley is asking Synthes, which makes an artificial spinal disk known as Prodisc, whether doctors whose Read more...
Congress probes med device payments
Should device makers retain surgeons as consultants? That's what the Senate Special Committee on Aging plans to discuss today at a hearing over some $221 million in payments five companies made to Read more...
Supreme Court shields device makers
Medical device makers got some supreme protection yesterday. The highest court raised a partial shield against lawsuits, saying that devices that passed the FDA's most stringent premarketing review Read more...
Stent sales stabilize as rival enters
In the stent world today, it's good news, good news, and bad news. First, the bad news: Last year's fourth quarter was the worst in several years for drug-coated stents. In December, only 62 percent Read more...
ALSO NOTED: Medtronic launches first Asian JV; Pfizer ups dividend by 10 percent;
> Medtronic is buying a 15 percent stake in a Chinese medical-device maker for $221 million and launching its first Asian joint venture. Read more...
| Press ReleasesPRESS RELEASE: Kyphon Stockholders Approve Merger with Medtronic Kyphon Stockholders Approve Merger with Medtronic SUNNYVALE, Calif., Oct 16, 2007 -- Kyphon announced today that its stockholders approved the adoption of the merger agreement with Medtronic at a Read more... PRESS RELEASE: Medtronic Voluntarily Suspends Distribution of Sprint Fidelis® Defibrillation Leads Medtronic Voluntarily Suspends Distribution of Sprint Fidelis® Defibrillation Leads Physician Experts Advise Against Prophylactic Replacement of Implanted Leads MINNEAPOLIS – October 15, 2007 – Read more... |
Get more Medtronic coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends